Disulfiram’s anticancer activity is mediated by its ability to suppress DNMT1 and through the reactivation of epigenetically silenced genes such as APC and RARB in prostate cancer cell lines (70) (Table 4, Section 1). The gene discussed is RARB; the disease is prostate carcinoma.